Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $582
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $575 to $582.
Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $575 to $582.